Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Tumour lysis syndrome: new therapeutic strategies and classification.

Cairo MS, Bishop M.

Br J Haematol. 2004 Oct;127(1):3-11. Review.

PMID:
15384972
2.

An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome.

Mughal TI, Ejaz AA, Foringer JR, Coiffier B.

Cancer Treat Rev. 2010 Apr;36(2):164-76. doi: 10.1016/j.ctrv.2009.11.001. Epub 2009 Dec 23. Review. Erratum in: Cancer Treat Rev. 2010 Aug;36(5):442.

PMID:
20031331
3.

Tumor lysis syndrome.

Jeha S.

Semin Hematol. 2001 Oct;38(4 Suppl 10):4-8. Review.

PMID:
11694945
4.

Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.

Cairo MS, Coiffier B, Reiter A, Younes A; TLS Expert Panel.

Br J Haematol. 2010 May;149(4):578-86. doi: 10.1111/j.1365-2141.2010.08143.x. Epub 2010 Mar 16. Review.

PMID:
20331465
5.

Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.

Coiffier B, Altman A, Pui CH, Younes A, Cairo MS.

J Clin Oncol. 2008 Jun 1;26(16):2767-78. doi: 10.1200/JCO.2007.15.0177. Review. Erratum in: J Clin Oncol. 2010 Feb 1;28(4):708.

PMID:
18509186
6.

The clinical management of tumour lysis syndrome in haematological malignancies.

Will A, Tholouli E.

Br J Haematol. 2011 Jul;154(1):3-13. doi: 10.1111/j.1365-2141.2011.08697.x. Epub 2011 May 9. Review.

PMID:
21554259
7.

Management of pediatric tumor lysis syndrome.

Tazi I, Nafl H, Elhoudzi J, Mahmal L, Harif M.

Arab J Nephrol Transplant. 2011 Sep;4(3):147-54. Review.

PMID:
22026339
8.

Tumor lysis syndrome in elderly.

Pumo V, Sciacca D, Malaguarnera M.

Crit Rev Oncol Hematol. 2007 Oct;64(1):31-42. Epub 2007 Jul 19. Review.

PMID:
17658268
9.

[Tumor lysis syndrome].

Jeddi R, Ben Abdennebi Y, Allani B, Belakhal R, Aissaoui L, Ben Abid H, Ali ZB, Meddeb B.

Tunis Med. 2007 Feb;85(2):174-6. Review. French.

PMID:
17665670
10.

Tumor lysis syndrome: a systematic review of case series and case reports.

Firwana BM, Hasan R, Hasan N, Alahdab F, Alnahhas I, Hasan S, Varon J.

Postgrad Med. 2012 Mar;124(2):92-101. doi: 10.3810/pgm.2012.03.2540. Review.

PMID:
22437219
11.

Tumor lysis syndrome.

Tiu RV, Mountantonakis SE, Dunbar AJ, Schreiber MJ Jr.

Semin Thromb Hemost. 2007 Jun;33(4):397-407. Review.

PMID:
17525897
12.
13.

Clarifying the role of rasburicase in tumor lysis syndrome.

Sood AR, Burry LD, Cheng DK.

Pharmacotherapy. 2007 Jan;27(1):111-21. Review.

PMID:
17192165
14.

The management of tumor lysis syndrome.

Rampello E, Fricia T, Malaguarnera M.

Nat Clin Pract Oncol. 2006 Aug;3(8):438-47. Review.

PMID:
16894389
15.

Tumour lysis syndrome: implications for cancer therapy.

Mika D, Ahmad S, Guruvayoorappan C.

Asian Pac J Cancer Prev. 2012;13(8):3555-60. Review.

16.

Oncological emergencies: tumor lysis syndrome.

Sobota J, Püsküllüoglu M, Zygulska AL.

Przegl Lek. 2014;71(4):210-4. Review.

PMID:
25141580
17.

Management of tumor lysis syndrome in adults.

Coiffier B, Riouffol C.

Expert Rev Anticancer Ther. 2007 Feb;7(2):233-9. Review.

PMID:
17288532
18.

A review of clinical and laboratory findings and treatment of tumor lysis syndrome.

Yarpuzlu AA.

Clin Chim Acta. 2003 Jul 1;333(1):13-8. Review.

PMID:
12809731
19.

Incidence and pathogenesis of tumor lysis syndrome.

Locatelli F, Rossi F.

Contrib Nephrol. 2005;147:61-8. Review.

PMID:
15604606
20.

A review of tumour lysis syndrome with targeted therapies and the role of rasburicase.

Bose P, Qubaiah O.

J Clin Pharm Ther. 2011 Jun;36(3):299-326. doi: 10.1111/j.1365-2710.2011.01260.x. Epub 2011 Apr 19. Review.

PMID:
21501203

Supplemental Content

Support Center